Literature DB >> 2370833

Ocular findings in beta-thalassemia.

R Sorcinelli1, A Sitzia, A Figus, M E Lai.   

Abstract

Eye examination was performed in a series of 53 patients whose mean age was 19.5 years (range from 11 to 25 years), affected from Cooley's disease, in treatment with transfusions and desferrioxamine in subcutaneous infusion. The most frequent ocular change was fundus mottling appearance like "leopard skin" (15%). We found also lens opacity (11%), drusen (7%), retinal venous tortuosity (5%), without impairment of visual acuity. The pathogenic factors of the ocular change are related to abnormality of iron metabolism. These results suggest that the involvement of desferrioxamine to remove iron from the eyeball is relatively small.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370833

Source DB:  PubMed          Journal:  Metab Pediatr Syst Ophthalmol (1985)        ISSN: 0882-889X


  6 in total

1.  Ocular findings in children with thalassemia major in Eastern Mediterranean.

Authors:  Adnan Aksoy; Murat Aslankurt; Lokman Aslan; Ozlem Gül; Mesut Garipardıç; Oğuz Celik; Seydi Okumuş; Murat Ozdemir; Gökhan Ozdemir
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

Review 2.  Ocular abnormalities in beta thalassemia patients: prevalence, impact, and management strategies.

Authors:  Samira Heydarian; Reza Jafari; Kiumars Nowroozpoor Dailami; Hassan Hashemi; Ebrahim Jafarzadehpour; Mohsen Heirani; Abbasali Yekta; Monireh Mahjoob; Mehdi Khabazkhoob
Journal:  Int Ophthalmol       Date:  2019-10-10       Impact factor: 2.031

Review 3.  Retinal abnormalities in β-thalassemia major.

Authors:  Devang L Bhoiwala; Joshua L Dunaief
Journal:  Surv Ophthalmol       Date:  2015-08-29       Impact factor: 6.048

Review 4.  β-Thalassemia and ocular implications: a systematic review.

Authors:  Aliki Liaska; Petros Petrou; Constantinos D Georgakopoulos; Ramza Diamanti; Dimitris Papaconstantinou; Menelaos G Kanakis; Ilias Georgalas
Journal:  BMC Ophthalmol       Date:  2016-07-08       Impact factor: 2.209

5.  Leopard-like retinopathy and severe early-onset portal hypertension expand the phenotype of KARS1-related syndrome: a case report.

Authors:  Francesca Peluso; Viviana Palazzo; Giuseppe Indolfi; Francesco Mari; Roberta Pasqualetti; Elena Procopio; Claudia Nesti; Renzo Guerrini; Filippo Santorelli; Sabrina Giglio
Journal:  BMC Med Genomics       Date:  2021-01-21       Impact factor: 3.063

Review 6.  Potential Treatment of Retinal Diseases with Iron Chelators.

Authors:  Wanting Shu; Joshua L Dunaief
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.